“…1,2 Since the poorly soluble drugs must be dissolved in the gastrointestinal lumen contents before oral absorption, improving the solubility and dissolution rate of poorly soluble APIs is rapidly becoming the leading hurdle for formulation scientists. 3,4 Consequently, a variety of strategies have been developed to overcome this obstacle for poorly water-soluble APIs, such as solid dispersions, 5,6 nanoemulsion, 7 salt formation, 8 melt extrusion, 9,10 liposomes, 11,12 nanostructured lipid carriers, 13,14 and micellar systems. 15,16 During the past several years, the use of particle size reduction methods to form stable nanosized particles has been proven to be an effective strategy to address this thorny problem.…”